Anandhkumar Raju
Papers
1
Total Citations
64
H-Index
1
About
Dr. Anandhkumar Raju is a leading researcher in cancer biology and therapeutic targeting, with a primary focus on protein myristoylation and its role in hematologic malignancies. His most cited work, "Targeting N-myristoylation for therapy of B-cell lymphomas" (2020, 64 citations), systematically investigates N-myristoyltransferase (NMT) as a promising anti-cancer target. Dr. Raju demonstrated that elevated NMT expression in cancer cells drives aberrant membrane signaling, and his pioneering studies have established the therapeutic potential of NMT inhibitors in B-cell lymphomas. By elucidating how myristate modification governs protein localization and oncogenic signaling, his research bridges fundamental biochemistry with translational oncology. With over 60 citations on this landmark paper alone, Dr. Raju's contributions have significantly advanced the understanding of post-translational modifications in cancer. His work not only identifies NMT as a druggable vulnerability but also provides a framework for developing targeted therapies that disrupt lipid-mediated signaling in aggressive lymphomas. For students and researchers, Dr. Raju exemplifies how mechanistic insights into protein modifications can lead to novel cancer treatment strategies.
Research Focus
Key Achievements
Top Papers
- 1Targeting N-myristoylation for therapy of B-cell lymphomas64 citations · 2020